Mutations in the human LMNA gene, which encodes the nuclear envelope proteins lamins A and C, cause Emery-Dreifuss muscular dystrophy (EDMD), congenital muscular dystrophy, limbgirdle muscular dystrophy, and a spectrum of other diseases. The molecular mechanisms responsible for these diseases remain incompletely understood, but the muscle-specific defects suggest that mutations may render nuclei more susceptible to mechanical stress. Using three mouse models of muscle laminopathies, we found that Lmna mutations reduced nuclear stability and caused widespread nuclear damage in skeletal muscle cells in vitro and in vivo, including the formation of chromatin protrusions, transient rupture of the nuclear envelope, DNA damage, and activation of DNA damage response pathways. Nuclear damage resulted from nuclear movement in maturing myotubes, and could be reversed by depletion of kinesin-1 or stabilization of microtubules surrounding the myonuclei. Inhibiting DNA-dependent protein kinase (DNA-PK), a major DNA damage response pathway, improved myofiber health, suggesting that DNA damage response signaling, rather than nuclear damage itself, causes the striated muscle defects. These findings point to the importance of DNA damage response pathways in post-mitotic muscle cells and open the door for novel therapeutic approaches for these currently untreatable diseases.
INTRODUCTION
The nuclear envelope proteins lamin A and C, together with the B-type lamins B1 and B2, are the major components of the nuclear lamina, which underlies the inner nuclear membrane. Lamins A/C play important roles in providing structural support to the nucleus and connecting the nucleus to the cytoskeleton 1 . In addition, they participate in transcriptional regulation, genome organization, and DNA damage and repair [1] [2] [3] [4] . The majority of the over 450 LMNA mutations identified to date are responsible for autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD) 5 . EDMD is characterized by slowly progressive skeletal muscle wasting, contractures of the elbow, neck, and Achilles tendons, a rigid spine, abnormal heart rhythms, heart block, and cardiomyopathy 6 . It remains unclear how LMNA mutations result in these tissue-specific defects, and the incomplete understanding of the disease pathogenesis presents a major hurdle in the development of effective treatment approaches. A major hypothesis regarding the disease mechanisms states that mutations in the LMNA gene result in mechanically weaker nuclei, making them more susceptible to force induced damage in mechanically stressed tissues, such as muscle, and leading to progressive muscle loss 4 .
Previous studies have reported anecdotal evidence of severe ultrastructural nuclear damageincluding blebbing and partial loss of the nuclear envelope, protrusion of chromatin into the cytoplasm, and intrusion of cytoplasmic organelles into the nucleoplasm-in skeletal muscle fibers of patients with EDMD [7] [8] [9] [10] , cardiac myocytes in LMNA-dilated cardiomyopathy patients 11, 12 , lamin A/C-deficient mice 13, 14 , and muscle and tendons of lamin-deficient fruit flies 15, 16 . However, systematic studies addressing the prevalence of these structural nuclear defects and the role of nuclear damage in the disease pathology remain elusive. Using three independent mouse models of striated muscle laminopathies, we evaluated the effect of Lmna mutations on nuclear mechanics and the downstream consequences in muscle cells in vitro and in vivo. We found that Lmna mutant muscle cells had structurally weaker nuclei, resulting in extensive nuclear damage in vitro and in vivo. The mechanically induced nuclear damage was associated with severe DNA damage in postmitotic muscle cells. Intriguingly, the resulting activation of DNA damage response pathways, rather than the nuclear damage itself, was responsible for the progressive decline in myofiber health, suggesting that inhibition of DNA damage response pathways could serve as a novel therapeutic approach for laminopathies affecting striated muscle.
RESULTS

Lmna mutations cause progressive decline in myofiber health in vitro and in vivo
To examine the effect of Lmna mutations on nuclear mechanics and muscle function in vitro, we isolated myoblasts from three established mouse models of striated muscle laminopathies, representing a spectrum of disease severity: Lmna -/-mice 13 , subsequently referred to as lamin A/Cknock-out mice (Lmna KO); knock-in mice carrying the Lmna N195K/N195K mutation (Lmna N195K) 17 ; knock-in mice carrying the Lmna H222P/H222P mutation (Lmna H222P) 18 ; and wild-type littermates (Fig. 1A) . While the Lmna N195K mice were originally described as a model for dilated cardiomyopathy 17 , in the C57BL/6 background used here, the mice developed pronounced muscular dystrophy in addition to the cardiac defects (Suppl. Fig. S1 ). For in vitro studies, we utilized a recently developed, three-dimensional culture protocol to differentiate primary myoblasts into mature, contractile myofibers over the course of 10-14 days (Fig. 1B ) 19 . The resulting myofibers display the highly organized sarcomeric structure and myonuclear positioning characteristic of mature skeletal muscle fibers in vivo (Suppl. Fig. S2 ).
All myoblasts, including the Lmna KO, Lmna N195K and Lmna H222P mutant cells, successfully completed myoblast fusion, differentiation into myotubes, formation of sarcomeric structures, and maturation into myofibers (Fig. 1C) , consistent with previous studies on differentiation of Lmna KO and Lmna H222P myoblast into myotubes [20] [21] [22] . Wild-type myofibers remained healthy and highly contractile up to 14 days of differentiation, however, the Lmna mutant myofibers showed a decline in health, reduction in total cell area, and loss of contractility by ten days ( Fig. 1C-E ; Suppl. Fig. S3 , Suppl. Movies 1-4). The reduction in total cell area at day 10 in the Lmna KO myofibers was associated with an increase in activated caspase-3 (Suppl. Fig. S4 ), indicating that at least some myofiber loss was due to cell-intrinsic apoptosis. Notably, the loss of muscle cell health, contraction, and total cell area closely correlated with the severity of the disease in the corresponding mouse models, with Lmna KO myofibers having the most severe phenotype, followed by the Lmna N195K and then the Lmna H222P models.
Lmna mutant muscle cells exhibit defective nuclear stability that correspond with disease severity Previous studies found that lamin mutations linked to muscular disease reduced nuclear stability in patient-derived skin fibroblasts and in a Drosophila model 23 . To test whether reduced nuclear stability contributed to the progressive deterioration of Lmna mutant myofibers, we measured the nuclear deformability in primary myoblasts from the three laminopathy models using a novel microfluidics-based cell aspiration assay ( Fig. 2A , Suppl. Movie 5). This assay is a higher throughput variation of the traditional micropipette aspiration technique commonly used to study nuclear mechanics 24, 25 . Nuclei from Lmna KO and Lmna N195K myoblasts were substantially more deformable than nuclei from wild-type controls (Fig. 2B, C) . Intriguingly, myoblasts from Lmna H222P mice, which have a much later disease onset and less severe muscle defects than the other two Lmna mutant models (Fig. 1A) , had only a modest increase in nuclear deformability relative to wild-type controls (Supp. Fig. S5A ). Ectopic expression of lamin A significantly reduced the nuclear deformability defect in primary Lmna KO myoblasts (Suppl. Fig. S5B-D) , confirming that the impaired nuclear stability was a direct consequence of altering the nuclear lamina. In addition, primary myoblasts from Mdx mice, which develop mild muscular dystrophy due to loss of dystrophin, a cell membrane protein, had nuclear deformation indistinguishable from wild-type controls (Suppl. Fig. S6 ), indicating that the defects in nuclear stability are specific to Lmna mutations and not muscular dystrophy in general.
To assess whether the observed defects in nuclear stability also occur in more mature, multinucleated myofibers, we subjected Lmna KO and wild-type myofibers to a 'microharpoon' assay 26, 27 , in which precise strain is exerted on the perinuclear cytoskeleton, and the induced nuclear deformation and displacement are used to infer nuclear stability and nucleo-cytoskeletal coupling, respectively 26 . Lmna KO myofibers had significantly more deformable nuclei than wildtype controls ( Fig. 2D, E ; Suppl. Movie 6), consistent with the micropipette aspiration results in the myoblasts. Furthermore, analysis of Lmna mutant and wild-type myofibers at five days of in vitro differentiation revealed that Lmna KO, Lmna N195K, and Lmna H222P myofibers had significantly elongated myonuclei compared to wild-type controls (Fig. 2F, G) , consistent with decreased nuclear stability in the Lmna mutant cells and with previous reports of elongated nuclei in muscle biopsies from laminopathy patients 28 . Taken together, these findings suggest that myopathic Lmna mutations result in mechanically weaker myonuclei.
Lmna mutant myonuclei display nucleus-intrinsic chromatin protrusions Analysis of nuclear shape and structure in myofibers differentiated from Lmna KO, Lmna N195K, and Lmna H222P myoblasts revealed striking chromatin protrusions that were completely absent in wild-type fibers. These protrusions extended beyond the (B-type) nuclear lamina up to tens of microns into the cytoplasm (Fig. 3A , B) and were enclosed by nuclear membranes, as indicated by the frequent presence of the nuclear membrane protein emerin, and occasionally nesprin-1 (Suppl .  Fig. S7A) ; however, these proteins were often concentrated in punctae inside the protrusions and myonuclei. Other nuclear envelope proteins, such as nuclear pore complex proteins, were largely absent from the protrusions (Supp. Fig. S7B ), suggesting an altered membrane composition in the chromatin protrusion, similar to what has been reported in analogous structures in cancer cells 29, 30 .
The frequency of chromatin protrusion was highest in Lmna KO myofibers, followed by Lmna N195K and then Lmna H222P myofibers (Fig. 3B) , correlating with the increased nuclear deformability in vitro (Fig. 2 ) and the disease severity in vivo (Fig. 1A) . Intriguingly, while Lmna KO and Lmna N195K myofibers had extensive chromatin protrusions at five days of differentiation, the frequency of chromatin protrusions in the Lmna H222P cells was initially very low, but increased significantly from five to ten days of differentiation (Fig. 3B) , matching the delayed disease onset and progressive phenotype in vivo. Ectopic expression of lamin A in Lmna KO myoblasts significantly reduced the occurrence of chromatin protrusions at ten days of differentiation (Fig. 3B) , confirming that the protrusions were caused by loss of lamin expression.
Single muscle fibers isolated from the hindlimbs of Lmna mutant mice had similar chromatin protrusions (Fig. 3C, D) , confirming their presence in vivo. In contrast, chromatin protrusions were not detectable in muscle fibers from wild-type mice (Fig. 3C, D) . Interestingly, the prevalence of chromatin protrusions in the Lmna mutant myonuclei strongly depended on the location within the muscle. Myonuclei at the myotendinous junctions (MTJ) had significantly higher rates of chromatin protrusions than nuclei in the muscle fiber body (Fig. 3D ).
To address whether the observed nuclear defects in Lmna mutant muscle cells are nucleus intrinsic, or arise from altered signaling pathways or other cytoplasmic changes in the mutant cells, we generated "hybrid" myofibers by combining Lmna KO and wild-type myoblasts. Following differentiation and myoblast fusion, these cells formed myofibers that contained both Lmna KO and wild-type nuclei with a shared cytoplasm (Fig. 3E) . We quantified the number of nuclei with chromatin protrusions and compared genetically identical nuclei (e.g., wild-type or Lmna KO) from hybrid and isogenic control myofibers after 10 days of differentiation (Fig. 3F) , with the genotype of each myonucleus determined by antibody staining against lamin A (Fig. 3E) . Hybrid myofibers comprising ~80% wild-type nuclei and ~20% Lmna KO nuclei appeared healthy. Nonetheless, Lmna KO nuclei within the hybrid myofibers showed the same relative frequency of chromatin protrusions as nuclei from isogenic Lmna KO myofibers (Fig. 3F) . Conversely, wildtype nuclei in hybrid fibers were not adversely affected by the presence of Lmna KO nuclei and lacked chromatin protrusions (Fig. 3F) . These results indicate that the defects in nuclear structure peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Nuclei in lamin A/C-deficient myofibers experience extensive nuclear envelope rupture in vitro and in vivo In addition to nuclear blebbing and protrusions of chromatin into the cytoplasm, muscle cells of patients with EDMD have anecdotally been found to contain inclusion of cytoplasmic organelles in the nucleoplasm [7] [8] [9] [10] , suggesting transient loss of nuclear envelope integrity. Furthermore, depletion of lamins, combined with cytoskeletal forces exerted on the nucleus, can result in nuclear envelope rupture 29, [31] [32] [33] [34] [35] . To examine whether the reduced nuclear stability seen in Lmna mutant muscle cells (Fig. 2 ) leads to nuclear envelope rupture in Lmna mutant myofibers, we genetically modified primary myoblasts to co-express a fluorescent nuclear envelope rupture reporter, consisting of a green fluorescent protein with a nuclear localization signal (NLS-GFP) 29 and fluorescently labeled histone (H2B-tdTomato). NLS-GFP is normally localized to the nucleus, but rapidly spills into the cytoplasm upon loss of nuclear membrane integrity and is then gradually reimported into the nucleus after the nuclear membrane has been repaired 29 . In vitro differentiated Lmna KO myotubes frequently exhibited nuclear envelope ruptures (Suppl. Movie 7), which were absent in wild-type controls. To investigate nuclear envelope rupture in more detail, we stably modified primary myoblasts with another fluorescent nuclear envelope rupture reporter, cGASmCherry. Upon nuclear envelope rupture, the cytoplasmic cGAS-mCherry reporter binds to the exposed genomic DNA and accumulates at the rupture site 29 ( Fig. 4A) ; unlike the transient cytoplasmic NLS-GFP signal, however, the cGAS-mCherry accumulation persists even after the nuclear envelope has been repaired 29, 31 . Lmna KO myotubes displayed a progressive increase in the number of nuclear cGAS-mCherry foci during differentiation, starting around day two, which could be rescued by ectopic expression of wild-type lamin A (Fig. 4A, B) . Accumulation of cGASmCherry in wild-type myotubes was hardly detectable (Fig. 4B) . Lmna N195K showed intermediate levels of nuclear envelope rupture (Suppl. Fig. S8 ), whereas Lmna H222P myotubes had cGAS-mCherry accumulation comparable to wild-type controls, consistent with the milder defects in nuclear stability in the Lmna H222P mutant cells (Suppl. Fig. S8 ).
To test whether nuclear envelope rupture occurs within Lmna KO muscle in vivo, we generated transgenic mice that express a fluorescent cGAS-tdTomato nuclear rupture reporter and crossed these mice into the Lmna KO mouse model. Single hindlimb muscle fibers isolated from Lmna KO offspring expressing the cGAS-tdTomato reporter revealed a large fraction of myonuclei with cGAS-tdTomato foci, which were absent in wild-type littermates expressing the cGAS-tdTomato reporter and in Lmna KO mice not expressing the cGAS-tdTomato reporter (Fig. 4C, D) . Within Lmna KO muscle fibers, the frequency of nuclear envelope rupture was significantly higher at the MTJ than in the myofiber body nuclei ( Fig. 4D ; Suppl. Fig. S9 ), consistent with the increased frequency of chromatin protrusions in the MTJ myonuclei. As an independent approach to detect loss of nuclear-cytoplasmic compartmentalization in muscle fibers, we analyzed the intracellular localization of endogenous heat shock protein 90 (Hsp90), which is typically excluded from the nucleus 36 . Muscle fibers isolated from Lmna KO mice, but not wild-type littermates, had a significant increase in nuclear Hsp90 (Suppl. Fig. S10 ), confirming the occurrence of nuclear envelope rupture in vivo. In our in vitro assays, all three Lmna mutant models revealed increased nuclear Hsp90 levels during myoblast differentiation (Suppl. Fig. S10 ). Taken together, these findings indicate widespread nuclear envelope rupture in laminopathic skeletal muscle.
Nuclear damage in Lmna KO myofibers can be prevented by microtubule stabilization
We surmised that nuclear envelope ruptures in Lmna mutant myofibers resulted from cytoskeletal forces acting on mechanically weak myonuclei, and that reducing mechanical stress on the nuclei would decrease nuclear damage. In striated muscle cells, microtubules form a cage-like structure around the myonuclei 37 (Suppl. Fig. S11 ). To test if stabilizing this microtubule network and thereby reinforcing myonuclei can reduce chromatin protrusions and nuclear envelope rupture, we treated in vitro differentiated myoblasts with low doses of the microtubule stabilizing drug, paclitaxel. Here and in the following work, we focused on the Lmna KO model, which showed the most severe nuclear defects. The microharpoon assay confirmed that microtubule stabilization reinforced Lmna KO nuclei in differentiated myofibers and significantly reduced nuclear deformation in response to cytoplasmic force application (Fig. 4E , Suppl. Movie 8). Furthermore, paclitaxel treatment significantly reduced the percentage of nuclei with chromatin protrusions (Fig.  4F ) and the incidence of nuclear envelope rupture detected with the cGAS-mCherry reporter in the Lmna KO cells (Fig. 4G ), suggesting that nuclear damage indeed arises from mechanical stress on the myonuclei.
Lmna KO myonuclei have increased levels of DNA damage in vitro and in vivo
Recent studies found that nuclear deformation and nuclear envelope rupture can cause DNA damage in migrating cells 29, 31, 38 . To investigate whether chromatin protrusions and nuclear envelope rupture can similarly lead to DNA damage in muscle cells, we quantified DNA damage in differentiating primary myoblasts by staining for H2AX, a marker for double stranded DNA damage 39 . Both Lmna KO and wild-type myoblasts had elevated levels of DNA damage at the onset of differentiation (Fig. 5A , B), consistent with previous reports that show the transition from myoblasts to myotubes is associated with a transient increase in H2AX levels 40, 41 . However, while H2AX levels in wild-type myotubes subsequently decreased and then remained stable at low levels, the fraction of myonuclei with severe DNA damage in the Lmna KO cells continued to increase from day five to ten days post differentiation, with nearly 20% of Lmna KO myonuclei exhibiting severe DNA damage by day 10 (Fig. 5B ). Single muscle fibers isolated from Lmna KO mice similarly contained many myonuclei with severe H2AX staining (Fig. 5C, D) , confirming the presence of extensive DNA damage in Lmna KO muscle fibers in vivo. In contrast, muscle fibers isolated from wild-type mice contained only low levels of DNA damage (Fig. 5C, D ).
Kinesin-mediated nuclear migration is responsible for nuclear damage in Lmna KO myonuclei Because the levels of nuclear damage and DNA damage were intrinsic to individual nuclei, we surmised that these defects arose from cytoskeletal forces acting on mechanically weaker nuclei. These forces could be generated by contractile actomyosin machinery that becomes increasingly organized during muscle differentiation, or from microtubule-associated motors involved in positioning myonuclei during early myotube maturation 42, 43 . Treatment of Lmna KO and wildtype myotubes with nifedipine, a calcium channel blocker, effectively abrogated myotube contraction, but did not reduce the frequency of chromatin protrusions in Lmna KO myonuclei (Suppl. Fig. S12 ). Therefore, we focused our attention to cytoskeletal forces exerted on the nucleus during nuclear migration in differentiating myotubes.
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/364778 doi: bioRxiv preprint first posted online Jul. 7, 2018; Time-lapse sequences of Lmna KO myoblasts expressing the NLS-GFP and/or cGAS-mCherry reporters revealed that nuclear envelope rupture frequently occurred during early stages of myotubes maturation, when the initially clustered nuclei are distributed along the length of myotubes by microtubule-associated motors (Fig. 6A) . Furthermore, chromatin protrusion lengths continued to increase during maturation in Lmna mutant myotubes (Suppl. Fig. S13 ). If chromatin protrusions and nuclear envelope rupture are caused by nuclear migration, then abolishing nuclear movement should reduce or prevent nuclear defects. Affirming this hypothesis, depletion of Kif5b, a subunit of kinesin-1 that is necessary for nuclear migration [42] [43] [44] , almost completely abolished chromatin protrusions ( Fig. 6B, C ; Suppl. Fig. S14 ) and nuclear envelope rupture (Fig. 6D , E) in Lmna KO myotubes. Furthermore, Kif5b depletion also substantially reduced DNA damage in the Lmna KO myotubes (Fig. 6F, G) , lending further support to the idea that DNA damage is linked to nuclear envelope rupture.
Decline of Lmna KO myofiber health is linked to activation of DNA-PK DNA damage response pathway While our studies linked muscle dysfunction to DNA damage, it was unclear if the DNA damage itself was causal for the defective muscle phentypes. Prior studies showed that increased activity of DNA-dependent protein kinase (DNA-PK), one of the major DNA damage sensing pathways 45 , is linked to the age-related decline of metabolic, mitochondrial and physical fitness of skeletal muscle cells 36 . In our experiments, DNA-PK activity significantly increased in Lmna KO myotubes during differentiation (Fig. 7A) , matching the progressive increase in DNA damage (Fig.  5B ).
To test whether increased DNA-PK activity was functionally involved in Lmna KO myofiber decline, we treated developing Lmna KO myofibers with the DNA-PK-specific inhibitor NU7741. Intriguingly, despite the continued presence of chromatin protrusions and nuclear envelope rupture, DNA-PK inhibition significantly improved the viability and health of Lmna KO myofibers ( Fig. 7B, C ; Suppl. Movies 9, 10). Independent inhibition of ATM and ATR, the other major cellular DNA damage response pathways 45 , did not significantly improve myofiber health (Suppl. Fig. S15 ). Taken together, these findings indicate that the mechanically induced DNA damage and the resulting DNA-PK activation are responsible for the progressive myofiber decline in laminopathies.
DISCUSSION
Here, we present comprehensive evidence from multiple in vitro and in vivo models of striated muscle laminopathies that demonstrate that Lmna mutations result in mechanically weaker myonuclei that experience substantial nuclear damage in muscle cells and tissues including chromatin protrusions, transient nuclear envelope rupture, and increased DNA damage. Intriguingly, the nuclear damage did not arise from muscle contractions, but from kinesin-1 mediated forces during nuclear migration, a key element in muscle differentiation and maturation 43 . Furthermore, we found that the DNA-PK activation in response to the mechanically induced DNA damage, rather than the nuclear damage itself, was driving the progressive decline in myofiber health in the Lmna mutant cells. This result was surprising, as DNA-PK inhibition significantly improved myofiber health despite the continued presence of chromatin protrusions peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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While we cannot exclude the possibility that altered cytoplasmic signaling pathways and impaired DNA damage repair in Lmna mutant myocytes contribute to the increased DNA damage 46 , the finding that Kif5b depletion significantly reduced DNA damage in Lmna KO cells suggest that the observed DNA damage was mechanically induced. Nonetheless, it remains unclear how nuclear damage and nuclear envelope rupture cause DNA damage. Possible mechanisms include exposure of genomic DNA to cytoplasmic nucleases or nuclear exclusion and efflux of DNA repair, as previously discussed in the context of confined cell migration 47, 48 .
Although we have seen abundant evidence of progressive cell death associated with nuclear envelope rupture and severe DNA damage, further investigations into the precise cause of myofiber decline and death are warranted. Muscle tissue is generally considered resistant to apoptosis and non-necrotic types of death have not been completely characterized 49 . In our studies, we found evidence of caspase-3 activation, but additional mechanisms, possibly triggered by DNA-PK activation, may further contribute to the decline in myocyte health, consistent with the recently identified role of DNA-PK in age-associated decline in muscle function 36 or canonical DNA-PK signaling 39 . DNA-PK signaling has been implicated in accelerated aging through telomere shortening, AMPK inhibition, fatty acid synthesis, and mitochondrial loss, with effects mediated by the phosphorylation of HSP90 in muscle cells 36, 50 . Interestingly, DNA-PK phosphorylates a number of other heat shock proteins, including HSP70 and HSP150, as well as lamin B1, -tubulin, desmoplakin and vimentins 51 , which could further contribute to disease progression in skeletal muscle of laminopathies.
In the in vitro models, kinesin-1 mediated nuclear movement was the main driver of nuclear damage. In vivo, however, acto-myosin generated forces are likely substantially larger than in the in vitro differentiated myofibers, and may further contribute to nuclear damage, particularly in mature muscle fibers. At the same time, the ongoing regeneration in dystrophic muscle 52 may result in an increased frequency of nuclear movement even in adult animals, which could further exacerbate the disease development. Insufficient anchoring of myonuclei within the muscle fiber, for example, at neuromuscular junctions 53 , could further promote nuclear damage in vivo. Contraction-induced nuclear damage may be particularly relevant in cardiac myocytes, whose dysfunction are the primary cause of death in striated muscle laminopathies 2 . Interestingly, our in vivo studies found that nuclear envelope rupture and DNA damage were more prevalent at the MTJ compared to the muscle body. The increased damage at the MTJ may be due to locally higher forces, altered nucleo-cytoskeletal organization, or yet to be identified factors. Intriguingly, the MTJ enriched nuclear damage correlates with previous findings of increased nuclear abnormalities and altered transcription at the MTJ in Lmna KO mice 54 and the clinical progression of EDMD in humans, which starts with joint contractures before the onset of muscle atrophy 6, 55, 56 .
Overall, these findings demonstrate the importance of lamins A/C to provide structural support to myonuclei required for healthy muscle function, and indicate that mechanically induced DNA damage and DNA-PK activation cause cellular decline and death even in postmitotic cells.
Importantly, the work presented here point to potential new clinical avenues for the currently untreatable laminopathies. While stabilizing microtubules with low doses of paclitaxel and depletion of kinesin-1 both reduced damage in Lmna KO myofibers, the associated detrimental long-term effects may preclude therapeutic use. In contrast, DNA-PK inhibition significantly improved myofiber health without adverse effects in vitro, even at 14 days (Fig. 7) , and has already been used in anti-cancer therapy in patients 57 . Thus, the striking effects of DNA-PK inhibition on Lmna KO myofiber health raises the exciting prospect of novel therapeutic approaches for laminopathies affecting striated muscle function.
Lastly, beyond striated muscle laminopathies, insights gained from this work are highly relevant to other biological systems in which nuclei are exposed to physical stress from the cytoskeleton. Examples include confined migration 58 or intracellular nuclear positioning in muscle, polarized epithelial, or neuronal cells 59 . In the brain, kinesin-1 applies localized forces to the nuclei of migrating neurons during cortex formation 60 . Since cortical neurons lack lamin A 61 , thus leaving B-type lamins as the major nuclear lamina components in these cells, nuclear damage through kinesin-mediated forces may lead to the severe neurodevelopment defects and nuclear abnormalities during brain development in mice lacking B-type lamins 62 . Taken together, these findings point to an important role of mechanically induced nuclear damage and activation of DNA damage response pathways, which could open new areas of research, particularly in post-mitotic cells, where DNA damage response pathways are currently underexplored. , and Lmna N195K/+ mice were backcrossed at least seven generations into a C57-BL/6 line. For each mouse model, heterozygous mice were crossed to obtain homozygous mutants, heterozygous mice, and wild-type littermates. Lmna mutant mice were provided with gel diet (Nutri-Gel Diet, BioServe) supplement to improve hydration and metabolism upon onset of phenotypic decline. Dmd mdx mice have been described previously 63 ; mice were obtained from the Jackson Laboratory in a C57BL background and hemi-or homozygous animals were bred to produce all hemi-and homozygous offspring. All mice were bred and maintained according to IACUC approved protocols. Data from wild-type littermate controls for Lmna KO, Lmna N195K and Lmna H222P showed no difference in any of the experimental outcomes between the different wild-type littermates, so wild-type data was combined into a single group unless otherwise specified. For both in vivo and in vitro studies, cells and or tissues were isolated from a single mouse and counted as a single replicate. All data are based on at least two independently derived primary cell lines for each genotype.
METHODS
Animals
Nuclear envelope rupture reporter mouse (cGAS/MB21D1-tdTom transgenic mouse). To detect NE ruptures in vivo, we generated a transgenic mouse expressing FLAG tagged human cGAS E225A/D227A fused to a tdTomato fluorescent protein (cGAS-tdTomato) under the control of the commonly used constitutive active CMV promoter. The cGAS mutations are in the magnesium-binding domain, abolishing the enzymatic activity and downstream production of interferon, while still remaining the ability to bind to genomic DNA. The mammalian expression cassette including promoter and terminator (CMV-3xFLAG-cGAS E225A/D227A -tdTomatoSV40polyA) was released from the expression vector, removing the prokaryotic domains. The purified linear DNA was then injected into the pronucleus of fertilized embryos collected from super-ovulated C57BL/6 mice and transplanted into pseudo-pregnant recipients. The resulting transgenic mouse model was used to cross into the Lmna KO background to generate 3×FLAG-cGAS E225A/D227A -tdTomato positive Lmna KO mice within two generations.
Myoblast isolation. Cells were harvested from Lmna KO, Lmna N195K, Lmna H222P, and wildtype littermates between 3-5 weeks for Lmna KO mice, 4-6 weeks for Lmna N195K, and 4-10 weeks for Lmna H222P mice using a protocol adapted from 13 . With the exception of the Lmna KO myoblasts, these time-points were prior to the onset of disease phenotypes. Myoblasts from wildtype littermates were harvested at the same time. Muscles of the lower hindlimb were isolated, cleaned of fat, nerve and excess fascia, and kept in HBSS on ice until all mice were harvested. The muscles were digested in 4 ml:1 g of tissue wet weight in a solution of 0.5% Collagenase II (Worthington Biochemicals), 1.2 U/ml Dispase (Worthington Biochemicals), 1.25 mM CaCl2 (Sigma) in HBSS/25 mM HEPES buffer. Digestion was carried out in a 37˚C water bath for a total time of 60 minutes. At 20 minutes intervals, digestion cocktails were removed and triturated 40 times with a 5 ml pipet. In the case of difficult to digest tissues, an extra 25% of 1% Collagenase II was added to the digestion after 40 minutes.
When tissues were fully digested, the reaction was quenched using equal volumes of DMEM supplemented with 10% fetal bovine serum (FBS) and 1% P/S (D10 media, Gibco). The cell suspension was strained through 40 and 70 μm filters (Greiner Bioscience) sequentially to remove peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/364778 doi: bioRxiv preprint first posted online Jul. 7, 2018; undigested myotube fragments and tendon. The cell suspension was centrifuged at 800 × g for 5 minutes and washed with 8 ml of D10 media for a total of four times. Cells were then resuspended in primary myoblast growth media (PMGM; Hams F-10 (Gibco) supplemented with 20% horse serum and 1% penicillin/streptomycin and 1 µl/ml basic fibroblast growth factor (GoldBio)) and plated onto a 2 % gelatin coated T25 flask. Cells were allowed to sit undisturbed for 72 hours. Capitalizing on the fact that myoblasts adhere much more weakly than fibroblasts, cells were passaged using PBS (calcium-and magnesium-free) instead of trypsin to purify the myoblasts. Cells were washed for 2-3 minutes at room temperature using a volume of PBS sufficient to coat the bottom of the flask and dislodged using manual agitation. When necessary, a 0.000625% trypsin solution was used to aid in the myoblast removal. Myoblasts were re-suspended in PMGM and re-plated onto gelatin coated flasks. This process was continued 3-4 times until pure myoblast cultures were achieved 64 . Cells were maintained in culture on gelatin coated flasks with media changes every other day. All experiments were carried out prior to passage 12. Each independent experiment was done on a different set of lamin mutant and wild-type littermates such that each independent experiment was sourced from a different animal to account for heterogeneity in phenotype.
Myoblast differentiation.
Myoblasts were differentiated according to a protocol modified from 19 . Coverslips for differentiation were prepared by first coating with CellTak (Corning) according to the manufacturer's protocol and then coating with growth factor reduced Matrigel (Corning) diluted 1:100 with IMDM with Glutamax (Gibco). Pre-cooled pipette tips were used to avoid premature polymerization. Matrigel was allowed to polymerize at 37˚C for 1 hour and the excess solution was aspirated. Primary myoblasts were seeded at a density of 55,000 cells/cm 2 in PMGM. Cells were allowed to attach for 24 hours before being switched to primary myoblast differentiation media (PMDM) composed of IMDM with Glutamax and 2% horse serum. One day after the onset of differentiation, a top coat of 1:3 Matrigel:IMDM was added to the cells and allowed to incubate for 1 hour at 37˚C. PMDM supplemented with 100 ng/ml agrin (R&D Systems) was added to the cells and henceforth replaced every second day. Cells were allowed to differentiate for a total of 0, 5, or 10 days.
Plasmids and generation of fluorescently labeled cell lines. Each of the mutant myoblast lines were stably modified with lentiviral vectors to express the nuclear rupture reporter NLS-GFP (pCDH-CMV-NLS-copGFP-EF1-blastiS) and cGAS-mCherry (pCDH-CMV-cGAS
E225A/D227A -mCherry2-EF1-blastiS. cGAS is a cytosolic DNA binding protein; we used a cGAS mutant (E225A/D227A) with abolished enzyme activity and interferon production, but that still binds DNA 65 and serve as a nuclear envelope rupture reporter 29 . For rescue experiments, Lmna KO cells were modified with human lamin A (pCDH-CMV-preLamin A-IRES-GFP-puro). Viral modification. Pseudoviral particles were produced as described previously 29 . In brief, 293-TN cells (System Biosciences, SBI) were co-transfected with the lentiviral plasmid using PureFection (SBI), following manufactures protocol. Lentivirus-containing supernatants were collected at 48 hours and 72 hours after transfection, and filtered through a 0.45 µm filter. Cells were seeded into 6-well plates so that they reached 50-60% confluency on the day of infection and transduced at most 2 consecutive days with the viral stock using the TransDux Max system (SBI). The viral solution was replaced with fresh culture medium, and cells were cultured for 24 hours before selection with 1 μg/mL of puromycin or 2 μg/mL blasticidin S for 2-5 days. After selection, peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Extended imaging using incubator microscope. Long term imaging was performed using an Incucyte imaging system, which allows for incubator imaging to minimize the effects of humidity and CO2 changes. The differentiating cells expressing combinations of NLS-GFP and cGASmCherry were imaged using the Incucyte dual color filter module from day 0 to day 10, every 30-60 minutes with a 20× objective. Resulting images were analyzed using the Incucyte software, which performs fluorescence background subtraction using a top hat method and then subsequent thresholding. cGAS-mCherry cells were thresholded and then analyzed for increase in fluorescent foci over time to track the rate of increase in nuclear envelope rupture or damage. NLS-GFP cells were used to investigate the frequency and presence of nuclear envelope rupture. To verify the results obtained from the Incucyte, cells were fixed and stained with appropriate antibodies to evaluate DNA damage and nuclear envelope rupture.
Isolation of single muscle fibers.
Single muscle fibers were harvested in a protocol adapted from Vogler et al. 66 . As previously described, fibers were isolated from male and female Lmna KO and wild-type litter mates at 5-6 weeks of age and Lmna H222P and wild-type litter mates were harvested at 6-8 weeks of age at 23-25 weeks of age in order to compare pre-and post-phenotype onset tissue 13, 18, 67 . While Lmna H222P male and female mice show differences in cardiac defects, they do not exhibit differences in progression of skeletal muscle defects 18, 67 , so both male and female mice were used for this analysis. Briefly, the EDL (extensor digitorus longus) and plantaris were isolated from the mouse and placed directly into a 1 ml solution of F10 media with 4,000 U/ml of Collagenase I (Worthington Biochemicals). The tissue was digested for 15-40 minutes depending on muscle size in a 37˚C water bath with agitation by inversion every 10 minutes. The reaction was quenched by transferring the digestion mixture to 4 ml of PMGM. Single fibers were hand-picked from the digested tissue using fire polished glass Pasteur pipettes. When necessary, the tissue was further dissociated by manual pipetting with a glass pipet. Fibers were washed once in fresh media prior to fixation with 4% paraformaldehyde (PFA) for 15 minutes at room temperature and subsequent IF staining.
Pharmacological treatments.
For preliminary experiments, myoblasts were differentiated using the standard protocol and treated with pharmacological treatments starting at day 5 of differentiation. For chromatin protrusion studies, paclitaxel was administered to differentiated myotubes in two 24 hours bursts at day 4 and day 6-post differentiation with a 24 hour recovery in between. Myotubes were then fixed in 4% PFA at day 7 and stained with anti-lamin B and DAPI in order to quantify the percentage of myonuclei with chromatin protrusions. For long term studies using the cGAS reporter, myotubes were treated with 10 nM of paclitaxel starting at day 5 and then media was refreshed every day. To inhibit myotube contraction, cells were treated with 5 µM nifedipine starting at day 5 and then media was refreshed every day. For DNA damage inhibitor experiments, cells were treated with NU7741 (1 μM), KU55933 (5 μM) and VE-821 (5 μM) starting at day 7 of differentiation through day 14 of differentiation.
Biophysical assays. To evaluate nuclear deformability in high throughput, we designed and fabricated a microfluidic, micropipette aspiration device. The mask and wafers were produced in the Cornell NanoScale Science and Technology Facility (CNF) using standard lithography peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/364778 doi: bioRxiv preprint first posted online Jul. 7, 2018; techniques. PDMS molds of the devices were cast using Sylgard 184 (Dow Corning) and mounted on coverslips using a plasma cleaner as described previously 29 . Three port entrances were made using a 1.2 mm biopsy punch. Pressures at the inlet and outlet ports were set to 1.0 and 0.2 psi (relative to atmospheric pressure, Patm), respectively, using compressed air regulated by a MCFS-EZ pressure controller (Fluigent) to drive single cells through the device. Myoblasts (~5×10 6 cells/mL suspended in 2 % bovine serum albumin (BSA), 0.2 % FBS and 10 μg/mL Hoechst 33342 DNA stain in PBS) were captured within an array of 18 pockets, and then forced to deform into 3 µm wide × 5 µm tall micropipettes. The selected pressures resulted in detectable nuclear deformations without causing significant damage to the cells (tested using propidium iodide staining). The remaining port was set to Patm and outfitted with a handheld pipette to flush cells from the pockets at the start of each image acquisition sequence. Brightfield and fluorescence images were acquired every 5 seconds for a minimum of 60 seconds using an inverted microscope and 20×/NA 0.8 air objective. Nuclear protrusion length was calculated using a custom-written MATLAB program.
For the microharpoon studies, myoblasts were seeded in 35 mm glass bottom dishes and differentiated as previously described, except without the addition of a Matrigel top coat to allow microharpoon access. A Sutter P-97 micropipette puller was used to create microharpoons from borosilicate glass rods (Sutter; OD: 1.0 mm, ID: 0.78, 10 cm length) with tip diameters of ≈1 μm. Day 4 myotubes (Lmna KO and wild type) were treated for 24 hours with either 50 nM Paclitaxel or the corresponding 0.1% DMSO. The following day, the microharpoon assay was performed as previously described by our laboratory 26 , with slight modifications to the pull parameters to accommodate myotubes. The microharpoon was inserted ≈5─7 μm from the edge of the nucleus and pulled 15 μm at a rate of 1 μm/s. Pull direction was always orthogonal to the long axis of the myofiber. Images were acquired at 40× (+1.6×) every 5 seconds. Nuclear strain and centroid displacement were calculated using a custom-written MATLAB program, made available upon request.
siRNA treatment. siRNAs used were as follows: Kif5b#3 (target sequence 5′-CAGCAAGAAGTAGACCGGATA-3′; Qiagen SI00176050), Kif5b#4 (target sequence 5′-CACGAGCTCACGGTTATGCAA-3′; Qiagen SI00176057), and non-target (NT) negative control (ON-TARGETplus non-targeting pool, Dharmachon, D-001810-10). Myoblasts were seeded on a Matrigel coating at a density of ~15,000 cells/well. Once adhered, the myoblasts were transfected twice, 48 hours apart, with siRNA for NT or Kif5b using Lipofectamine RNAiMAX at a concentration of 150 nM in PMGM. After 12 hours, the myoblasts were switched to PMDM and differentiated for 5 days.
Immunofluorescence staining. Cells were fixed in pre-warmed 4% PFA at the appropriate time point(s) and washed with PBS. Cells were blocked and permeabilized with a solution of 3% BSA, 0.1% Triton-X 100 and 0.1% Tween (Sigma) for 1 hour at room temperature. Cells were stained with primary antibodies diluted in blocking solution according to Table 2 at 4˚C overnight. Samples were washed with PBS and incubated for 1 hour at room temperature with 1:250 dilution of AlexaFluor antibodies (Invitrogen) and 1:1000 DAPI (Sigma). Single muscle fibers were stained using the same procedure in Eppendorf tube baskets with an increase in blocking solution Triton-X concentration to 0.25%.
Western blotting. Cells were lysed in RIPA buffer containing protease (cOmplete EDTA-Free, Roche) and phosphatase (PhosSTOP, Roche) inhibitors. Protein was quantified using Bio-Rad Protein Assay Dye and 25-30 µg of protein lysate was separated using a 4-12% Bis-Tris polyacrylamide gel using standard a standard SDS-Page protocol. Protein was transferred to a polyvinylidene fluoride (PVDF) membrane overnight at 4˚C at a current of 40 mA. Membranes were blocked using 3% BSA in tris-buffered saline containing 0.1% Tween-20 and primary antibodies (Table 2) were diluted in the same blocking solution and incubated overnight at 4˚C. Protein bands were detected using either IRDye 680LT or IRDye 800CW (LI-COR) secondary antibodies, imaged on an Odyssey® CLx imaging system (LI-COR) and analyzed in Image Studio Lite (LI-COR) Imaging acquisition. Cells on coverslips and mounted single muscle fibers were imaged with an inverted Zeiss LSM700 confocal microscope. Z-stack were collected using 20 air (NA = 0.8), 40 water-immersion (NA = 1.2) and 63 oil-immersion (NA = 1.4) objectives. Airy units for all images were set between 1 and 1.5. Epi-fluorescence images were collected on a motorized inverted Zeiss Observer Z1 microscope equipped with CCD cameras (Photometrics CoolSNAP EZ or Photometrics CoolSNAP KINO) or a sCMOS camera (Hamamatsu Flash 4.0). H&E histology images were collected on an inverted Zeiss Observer Z1 microscope equipped with a color CCD camera (Edmund Optics, EO-0312C).
Image analysis. Image sequences were analyzed using ZEN (Zeiss), ImageJ, or MATLAB (Mathworks) using only linear adjustments uniformly applied to the entire image region. Region of interest intensities were extracted using ZEN or ImageJ. To quantify cell area and myofiber health, maximum intensity protections were generated, which were then blinded to the observer. Cell area was calculated using thresholding of the actin and myosin heavy chain fluorescent signal. Myofiber health was scored according to the scale provided in (Suppl. Fig. S3 ). To count the number of DNA protrusions, and DNA damage foci, confocal image stacks were threedimensionally reconstructed and displayed as maximum intensity projections. Protrusions lengths were both counted and measured by the presence of DAPI signal beyond the lamin B rim of the nucleus. Aspect ratio was quantified based on a thresholded lamin B rim to avoid the confounding factor of the DNA protrusions outside the body of the nucleus. Nuclear rupture was detected by an increase of the cytoplasmic NLS-GFP signal, or the localization of cGAS-mCherry to the nucleus. For better visualization of NLS-GFP cells many of the fluorescent single color image sequences were inverted. Graphs were generated in Excel (Microsoft), and figures were assembled in Illustrator (Adobe). DNA damage was determined by counting H2AX foci and then binned based on foci number. If damage was so severe that individual foci could not be counted, these nuclei were placed in the >25 foci category. For Hsp90 quantification, average nuclear Hsp90 fluorescence intensity was determined from a single mid-nucleus z-plane image and normalized to the cytoplasmic intensity at two points immediately adjacent to the nucleus.
Statistical Analysis. Unless otherwise noted, all experimental results were taken from at least three independent experiments and in vivo data were taken from at least three animals. For data with normal distribution, we used either student's t-tests (comparing two groups) or one-way ANOVA (for experiments with more than two groups) with post-hoc tests. When multiple comparisons were made, we adjusted the significance level using Bonferroni corrections. All tests were performed using GraphPad Prism. Micropipette aspiration data were natural log-transformed (Suppl. Fig.   peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/364778 doi: bioRxiv preprint first posted online Jul. 7, 2018; S5A) and analyzed by linear regression of the log-log data. In addition, data was analyzed with a multilevel model, in which the log-transformed protrusion length was the dependent variable in the model and the log-transformed time, genotype, and their interaction were treated as independent fixed effects. Variance from individual experiments and other effects were considered in the model as random effects. Post-hoc multiple comparisons test with Dunnett correction were performed to determine differences between Lmna mutant cells (Lmna KO, Lmna N195K, and Lmna H222P) and control cells (pooled wild-type). Analyses were carried out using JMP software. Unless otherwise noted, * denotes p ≤ 0.05, ** denotes p ≤ 0.01, and *** denotes p ≤ 0.001. Unless otherwise indicated, error bars represent the standard error of the mean (SEM). peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/364778 doi: bioRxiv preprint first posted online Jul. 7, 2018; Figure 7 . DNA-PK inhibition improves Lmna KO myofiber health. (A) Quantification of DNA-PK activity in Lmna WT and Lmna KO myotubes at day 5 of differentiation by probing for the phosphorylation of DNA-PK at S2053, an autophosphorylation specific site. n = 3 lysates from independent cell lines. **, p < 0.01 vs. Lmna WT. (B) Representative images of Lmna KO myofiber health following treatment with the DNA-PK inhibitor NU7741 (1 µM) during days 7-14 of differentiation. Scale bar = 50 µm. (C) Quantification of total cell area in Lmna WT and Lmna KO myofibers following DNA-PK inhibition during days 7-14 of differentiation. n = 3-4 independent cell lines. *, p < 0.05 vs. respective genotype DMSO control.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/364778 doi: bioRxiv preprint first posted online Jul. 7, 2018; Figure 8 . Proposed mechanism by which Lmna mutations result in myofiber dysfunction and death. (A) Kinesin-1 motor proteins spread myonuclei along the myotubes axis during differentiation. In Lmna mutant cells, which have mechanically weaker nuclei, the localized forces associated with nuclear migration cause chromatin protrusion and nuclear envelope ruptures. This mechanically induced nuclear damage results in DNA damage, detected by H2AX foci, and activation of the DNA-PK pathway, which leads to decline in myofiber health and cell death. (B) Schematic flow chart delineating the steps described in panel A, along with interventions explored in this work. Stabilizing microtubules surrounding the myonuclei reinforces the Lmna mutant nuclei and prevents chromatin protrusions and nuclear envelope ruptures. Inhibiting nuclear movement by Kif5b depletions similarly prevents nuclear damage. Muscle contractions may also contribute to nuclear damage in vivo. Inhibiting DNA-PK inhibition rescues myofiber health, despite the continued presence of nuclear damage.
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